Literature DB >> 29164473

Clinicopathological and Immunohistochemical Study of Head and Neck Langerhans Cell Histiocytosis from Latin America.

Natália Rocha Bedran1, Román Carlos2, Bruno Augusto Benevenuto de Andrade3, Ana Paula Silva Bueno4, Mário José Romañach5, Cristiane Bedran Milito1.   

Abstract

Langerhans cell histiocytosis (LCH) is an inflammatory myeloid neoplastic proliferation with variable clinical behavior caused by the accumulation of CD1a+/CD207+ histiocytes, associated with a variable number of eosinophils, lymphocytes, plasma cells and multinucleated giant cells, most commonly observed in male children. LCH is uncommon in the head and neck region, occurring as ulcerated and reddened plaques or nodules that cause destruction of adjacent soft tissues and bone. The exact etiology of LCH is still unknown and controversial, with possible etiologic role of viruses, including Epstein-Barr virus (EBV). The aim of this study was to describe the clinicopathologic and immunohistochemical features of patients with LCH of the head and neck region. Clinical data from 19 patients with LCH were obtained from the archives of the Federal University of Rio de Janeiro and the Clinical Head and Neck Center of Guatemala. All cases were submitted to morphological, immunohistochemical analysis with CD1a, CD207, CD3, CD20, CD68, S-100 and Ki-67 and in situ hybridization for EBV. Ten cases were female and 9 male, with mean age of 11.5 years. Fourteen cases were located in the oral cavity, three cases in lymph nodes, and two cases in the scalp. In regard to the oral lesions, 13 cases were intra-osseous with six cases in anterior mandible, five cases in posterior mandible, and two cases in posterior maxilla while one case was located exclusively in the gingiva. The inflammatory pattern showed variation in the number of plasma cells, eosinophils and lymphocytes, while tumor cells were positive for CD1a, S-100 and CD68 in all cases, and positive for CD207 in 18 cases. In situ hybridization for EBV were negative in all cases.

Entities:  

Keywords:  Head and neck; Immunohistochemistry; Langerhans cell histiocytosis; Oral cavity

Mesh:

Year:  2017        PMID: 29164473      PMCID: PMC6232207          DOI: 10.1007/s12105-017-0867-1

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  49 in total

1.  Langerhans cell histiocytosis presenting in the neonatal period: a retrospective case series.

Authors:  S L Stein; A S Paller; P R Haut; A J Mancini
Journal:  Arch Pediatr Adolesc Med       Date:  2001-07

Review 2.  Langerhans cell histiocytosis: literature review and descriptive analysis of oral manifestations.

Authors:  Cristina Madrigal-Martínez-Pereda; Vanesa Guerrero-Rodríguez; Blanca Guisado-Moya; Cristina Meniz-García
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2009-05-01

3.  BRAFV600E mutation in cutaneous lesions of patients with adult Langerhans cell histiocytosis.

Authors:  E Varga; I Korom; H Polyánka; K Szabó; M Széll; E Baltás; Zs Bata-Csörgő; L Kemény; J Oláh
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-10-28       Impact factor: 6.166

4.  Radiologic features of eosinophilic granuloma of bone.

Authors:  R David; R A Oria; R Kumar; E B Singleton; M M Lindell; A Shirkhoda; J E Madewell
Journal:  AJR Am J Roentgenol       Date:  1989-11       Impact factor: 3.959

5.  BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis.

Authors:  Felix Sahm; David Capper; Matthias Preusser; Jochen Meyer; Albrecht Stenzinger; Felix Lasitschka; Anna-Sophie Berghoff; Antje Habel; Marion Schneider; Andreas Kulozik; Ioannis Anagnostopoulos; Leonhard Müllauer; Gunhild Mechtersheimer; Andreas von Deimling
Journal:  Blood       Date:  2012-08-02       Impact factor: 22.113

6.  Histiocytic disorders with spontaneous regression in infancy.

Authors:  K A Jang; S J Ahn; J H Choi; K J Sung; K C Moon; J K Koh
Journal:  Pediatr Dermatol       Date:  2000 Sep-Oct       Impact factor: 1.588

7.  Clinical spectrum of cutaneous Langerhans' cell histiocytosis mimicking various diseases.

Authors:  Kerstin Querings; Hans Starz; Bernd-Rüdiger Balda
Journal:  Acta Derm Venereol       Date:  2006       Impact factor: 4.437

8.  Expression of Epstein-Barr virus in Langerhans' cell histiocytosis.

Authors:  Misuzu Shimakage; Toshiyuki Sasagawa; Michio Kimura; Tatsuya Shimakage; Shiro Seto; Ken Kodama; Haruhiko Sakamoto
Journal:  Hum Pathol       Date:  2004-07       Impact factor: 3.466

9.  Maxillofacial manifestations of Langerhans cell histiocytosis: a clinical and therapeutic analysis of 10 patients.

Authors:  A Eckardt; A Schultze
Journal:  Oral Oncol       Date:  2003-10       Impact factor: 5.337

10.  Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years.

Authors:  Riccardo Haupt; Milen Minkov; Itziar Astigarraga; Eva Schäfer; Vasanta Nanduri; Rima Jubran; R Maarten Egeler; Gritta Janka; Dragan Micic; Carlos Rodriguez-Galindo; Stefaan Van Gool; Johannes Visser; Sheila Weitzman; Jean Donadieu
Journal:  Pediatr Blood Cancer       Date:  2012-10-25       Impact factor: 3.167

View more
  3 in total

Review 1.  [Identification of rare diseases in the oral cavity].

Authors:  Marcel Hanisch; Susanne Jung; Johannes Kleinheinz
Journal:  Internist (Berl)       Date:  2018-09       Impact factor: 0.743

2.  Epstein-Barr Virus-Associated Langerhans Cell Histiocytosis of the Thyroid Gland.

Authors:  Jijgee Munkhdelger; Patravoot Vatanasapt; Chamsai Pientong; Somboon Keelawat; Andrey Bychkov
Journal:  Head Neck Pathol       Date:  2020-11-02

3.  Langerhans cell histiocytosis: A diagnostic enigma in the oral cavity.

Authors:  Latha Mary Cherian; Dhanya Sasikumar; Pradeesh Sathyan; Binuja Elsa Varghese
Journal:  J Oral Maxillofac Pathol       Date:  2021-03-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.